Thea Messel
Founder, General partner @ Unconventional Ventures
Thea Messel is a seed investor at Unconventional Ventures focused on Health Care and Biotechnology. Thea Messel
- Total investments:
- 7
- Last investment:
- Lead investor:
- 57%
Last updated:
For AI agents: llms.txt
Industries Thea Messel invests in
Stages Thea Messel invests in
Countries Thea Messel invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1.9M–$5.2M
- Series A
- $4.7M–$5.9M
Investment Focus
Industry
- Health Care 2 (29%)
- Biotechnology 2 (29%)
- Software 1 (14%)
- Biopharma 1 (14%)
- Wholesale 1 (14%)
Stage
- Seed 4 (57%)
- Pre-Seed 1 (14%)
- Series A 1 (14%)
Country
- Denmark 3 (43%)
- Sweden 2 (29%)
- Spain 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Visibuilt is to pioneer sustainable road-building solutions by replacing standard asphalt with cutting-edge, environmentally friendly materials. | $3.8M / Seed / Jul 14, 2026 | ||
| Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry. | $5.9M / Series A / Jan 22, 2026 | ||
| Women aged 20-45 cannot get screened for breast cancer because existing solutions are unreliable. However, 81% want to. At The Blue Box, we have built a pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine with a sensitivity of 83%. In 2024, we’ll launch into the market, bringing The Blue Box to private gynecologyclinics with a Diagnostics-as-a-Service subscription model, and a pay-per-test revenue stream that we’ll share with doctors. | $3.8M / Seed / Nov 18, 2025 | ||
| Cellugy is a biotech firm transforming industrial materials through biofabricated cellulose. With strong funding and a clear growth trajectory, they’re scaling EcoFLEXY across personal care, packaging, and beyond, advancing the green transition and the fight against plastic pollution. | $5.2M / Seed / May 21, 2024 | ||
| Saveggy develops a bio-based edible vegan coating for fruit and vegetables eliminating plastic while keeping its protecting properties. | $1.9M / Seed / Apr 15, 2024 | ||
| Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry. | $4.7M / Series A / Nov 08, 2023 | ||
| Panion is a community-building tool that helps companies, schools, and organizations facilitate more social interactions amongst its members. The platform is entirely keyword searchable and filterable so members are able to search for each other based on common interests, values, goals or experiences and even narrow their searches by location,gender, age, language and much more. Members and admins can propose spontaneous events within the network and form social groups around an interest. Community admins are given a dashboard of analytics to track trends in their community and send segmented messages based on interest and location. | $242K / Pre-Seed / Jun 01, 2019 |
Co-Investors
About Unconventional Ventures
Unconventional Ventures is a Nordic early-stage investment firm that invest in: 1) Scalable impact tech 2) at the Pre-seed/seed stage, 3) Founded by underrepresented founders: women, LGBTQ, POC 4) Targeting global market opportunitiesWe believe that underrepresented founders represent one of the biggest market opportunities today, and bytargeting these founders we can access the following investment opportunities;
Unconventional Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alexis Horowitz-Burdick
General Partner
|
|||
Karoline Sjødal Olsen
Founders Collective
|
|||
Marie Mostad
Founder Collective, advisor
|
|||
Merete Nygaard
Founders Collective
|
|||
Nora Bavey
General Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Thea Messel invest in?
Thea Messel invests primarily in Health Care, Biotechnology and Software startups, most often at Seed and Pre-Seed stage. Most of the 7 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Thea Messel invest in?
Thea Messel typically joins rounds of $1.9M–$5.2M at Seed and $4.7M–$5.9M at Series A. These are whole funding-round sizes, not Thea Messel's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Thea Messel took part in.
How do I contact Thea Messel?
Public channels for Thea Messel include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Thea Messel last invest?
The most recent investment recorded for Thea Messel closed in Jul 2026. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
